These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28377050)

  • 1. Deciphering the effects of nelfinavir and lopinavir on epimastigote forms of Trypanosoma cruzi.
    Sangenito LS; de Guedes AA; Gonçalves DS; Seabra SH; d'Avila-Levy CM; Santos ALS; Branquinha MH
    Parasitol Int; 2017 Oct; 66(5):529-536. PubMed ID: 28377050
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms.
    Sangenito LS; Menna-Barreto RFS; Oliveira AC; d'Avila-Levy CM; Branquinha MH; Santos ALS
    Int J Antimicrob Agents; 2018 Aug; 52(2):185-194. PubMed ID: 29635008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
    Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH
    PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity.
    Sangenito LS; d'Avila-Levy CM; Branquinha MH; Santos ALS
    Int J Antimicrob Agents; 2016 Dec; 48(6):703-711. PubMed ID: 27838277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi.
    Sangenito LS; Gonçalves DS; Seabra SH; d'Avila-Levy CM; Santos AL; Branquinha MH
    Int J Antimicrob Agents; 2016 Oct; 48(4):440-4. PubMed ID: 27499433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
    Kraus M; Müller-Ide H; Rückrich T; Bader J; Overkleeft H; Driessen C
    Leuk Res; 2014 Mar; 38(3):383-92. PubMed ID: 24418752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.
    Besse A; Stolze SC; Rasche L; Weinhold N; Morgan GJ; Kraus M; Bader J; Overkleeft HS; Besse L; Driessen C
    Leukemia; 2018 Feb; 32(2):391-401. PubMed ID: 28676669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
    Kim JY; Park YJ; Lee BM; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JVG9, a benzimidazole derivative, alters the surface and cytoskeleton of Trypanosoma cruzi bloodstream trypomastigotes.
    Díaz-Chiguer DL; Hernández-Luis F; Nogueda-Torres B; Castillo R; Reynoso-Ducoing O; Hernández-Campos A; Ambrosio JR
    Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):757-60. PubMed ID: 25317703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: trypanocidal effect of 2(3)-tert-butyl-4-hydroxyanisole (BHA) on several strains of epimastigote and trypomastigote forms.
    Aldunate J; Ojeda JM; Repetto Y; Letelier ME; Spencer P
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1994 Oct; 109(2):119-27. PubMed ID: 7881815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.
    Santos LO; Garcia-Gomes AS; Catanho M; Sodre CL; Santos AL; Branquinha MH; d'Avila-Levy CM
    Curr Med Chem; 2013; 20(25):3116-33. PubMed ID: 23298141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase.
    Castilho VVS; Gonçalves KCS; Rebello KM; Baptista LPR; Sangenito LS; Santos HLC; Branquinha MH; Santos ALS; Menna-Barreto RFS; Guimarães AC; d'Avila-Levy CM
    BMC Res Notes; 2018 Nov; 11(1):825. PubMed ID: 30463602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of mitochondrial function as the basis of the trypanocidal effect of trifluoperazine on Trypanosoma cruzi.
    Lacuara JL; de Barioglio SR; de Oliva PP; Bernacchi AS; de Culasso AF; Castro JA; Franke de Cazzulo BM; Cazzulo JJ
    Experientia; 1991 Jun; 47(6):612-6. PubMed ID: 1829686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural alterations induced by the neolignan dihydrobenzofuranic eupomatenoid-5 on epimastigote and amastigote forms of Trypanosoma cruzi.
    Luize PS; Ueda-Nakamura T; Dias Filho BP; Cortez DA; Morgado-Díaz JA; de Souza W; Nakamura CV
    Parasitol Res; 2006 Dec; 100(1):31-7. PubMed ID: 16783543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of suramin on trypomastigote forms of Trypanosoma cruzi: changes on cell motility and on the ultrastructure of the flagellum-cell body attachment region.
    Bisaggio DF; Campanati L; Pinto RC; Souto-Padrón T
    Acta Trop; 2006 May; 98(2):162-75. PubMed ID: 16716244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi.
    Maya JD; Repetto Y; Agosín M; Ojeda JM; Tellez R; Gaule C; Morello A
    Mol Biochem Parasitol; 1997 May; 86(1):101-6. PubMed ID: 9178272
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-Trypanosoma cruzi activity of nicotinamide.
    Soares MB; Silva CV; Bastos TM; Guimarães ET; Figueira CP; Smirlis D; Azevedo WF
    Acta Trop; 2012 May; 122(2):224-9. PubMed ID: 22281243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Light- and electronmicroscopic studies on mastigote and amastigote stages of Trypanosoma cruzi under the influence of Lampit (author's transl)].
    Voigt WH; Haberkorn A; Gönnert R
    Z Parasitenkd; 1973 Jul; 41(4):255-67. PubMed ID: 4355120
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi.
    Lechuga GC; Borges JC; Calvet CM; de Araújo HP; Zuma AA; do Nascimento SB; Motta MCM; Bernardino AMR; Pereira MCS; Bourguignon SC
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):154-164. PubMed ID: 27490082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.
    Piccinini M; Rinaudo MT; Anselmino A; Buccinnà B; Ramondetti C; Dematteis A; Ricotti E; Palmisano L; Mostert M; Tovo PA
    Antivir Ther; 2005; 10(2):215-23. PubMed ID: 15865215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.